Frontiers Lu-177-PSMA dosimetry for kidneys and tumors based on

Lu-177 PSMA therapy in Germany

Fibroblast activation protein-based theranostics in cancer

Hotspots and frontiers in PSMA research for prostate cancer: a

Pharmaceuticals, Free Full-Text

Frontiers Precision strikes: PSMA-targeted radionuclide therapy

Frontiers Towards Routine Clinical Use of Dosimetry in [177Lu]Lu

Biodistribution data of 44 Sc-PSMA-617 and 177 Lu-PSMA-617

Frontiers Current role of prostate-specific membrane antigen

Radiation Dosimetry in 177Lu-PSMA-617 Therapy - ScienceDirect

Frontiers 177Lu-PSMA-I&T Radioligand Therapy for Treating

Frontiers 177Lu-labeled PSMA targeting therapeutic with